Nissha Co.ltd. · TSE:7915

Nissha Co.ltd — FY2022 Q1 Earnings Presentation

11 slides from Nissha Co.ltd's earnings presentation, May 12, 2022

  1. Slide 1: Financial Results for FY2022 Q1

    Financial Results for FY2022 Q1 Ended March 31, 2022 May 12, 2022 Junya Suzuki President and CEO Nissha Co., Ltd.

  2. Slide 2: Highlights

    Highlights FY2022 Q1 Result ⚫ Tailwinds ⚫ Steady product demand in non-IT priority markets (Medical Devices, Mobility, and Sustainable Materials) ⚫ Product price increase carried out (Metallized paper, etc.) ⚫ Headwinds ⚫ Cost soaring continue (raw materials, labors, and energy costs), especially in

  3. Slide 3: FY2022 Q1 Results

    FY2022 Q1 Results ⚫ While product demand for smartphones in Devices decreased, product demand in Industrial Materials and Medical Technologies increased steadily. ⚫ Profitability improved QoQ despite cost increase. (Millions of JPY) FY2021 FY2021 FY2022 Q1 Q4 Q1 YoY QoQ Results Results Results Net s

  4. Slide 4: Industrial Materials

    Industrial Materials ⚫ Steady product demand ⚫ Product price increased in Sustainable Materials due to cost soaring Net sales trend by ■Sustainable Materials (Metallized paper) (Millions of JPY) application (by quarter) ■Decoration (Others) ■Decoration (Mobility) 20,000 16,259 16,785 15,520 15,000 1

  5. Slide 5: Newly opened Nissha Sustainable Technology Center

    Newly opened “Nissha Sustainable Technology Center” Development base for Sustainable Molded Products Development Mass Production Nissha Sustainable Technology Center Nissha Schuster Kunststofftechnik (Koka, Shiga pref.) (Injection molding in Germany) Production process Transfer Engineering know-how

  6. Slide 6: Devices

    Devices ⚫ Demand for smartphones declined, as assumed. ⚫ Demand for tablet devices has been pushed back to Q2. Net sales trend by ■ ■Portable game players, Industrial equipment application (by quarter) (logistics related), Mobility, Gas sensors and others (Millions of JPY) ■ ■Tablet devices, Smartph

  7. Slide 7: Medical Technologies

    Medical Technologies ⚫ Strong demand mainly on CDMO ⚫ Cost soaring of raw materials, transportation, and labor depressed profits (2021 Q3~) ⚫ Carrying out product price increase and cost reduction to improve profitability Net sales trend by ■ ■Business media (Millions of JPY) ■ ■Medical devices (Own

  8. Slide 8: Revision of the forecast

    Revision of the forecast Net sales and operating profit for H1 and full-year has been revised upward (H2 remained as is). Reviewed H1 demand and profitability based on Q1 results. (Millions of JPY) Previous forecast (February 14) Revised forecast (May 12) FY2022 FY2022 FY2022 FY2022 FY2022 FY2022 Fu

  9. Slide 9: Reference: Capital investment, Depreciation and amortization, M&A investment, R&D

    Reference: Capital investment, Depreciation and amortization, M&A investment, R&D (Millions of JPY) FY2022 Q1 Results Capital 1,784 investment Depreciation and 2,280 amortization M&A investment - R&D 842 ©2022 Nissha Group 9

  10. Slide 10: Reference: Capital investment, Depreciation and amortization, R&D

    Reference: Capital investment, Depreciation and amortization, R&D Depreciation and Capital investment R&D amortization (Millions of JPY) (Millions of JPY) (Millions of JPY) 15,000 15,000 5,000 4,000 * 3,659 10,000 10,000 3,600 10,074 3,000 9,900 9,258 9,000 8,948 2,869 2,947 8,401 7,855 7,040 2,000

  11. Slide 11: Forward-looking information notice

    Among the information included in this presentation and provided at investor briefings and conferences, performance targets, plans, outlooks, strategies and other information that is not constituted of actual past facts, is information that has been judged reasonable by the managers of the Company b

Nissha — FY2022 Q1 Earnings Presentation on 6ix